UK markets open in 7 minutes
  • NIKKEI 225

    27,049.47
    +178.20 (+0.66%)
     
  • HANG SENG

    22,354.24
    +124.72 (+0.56%)
     
  • CRUDE OIL

    111.29
    +1.72 (+1.57%)
     
  • GOLD FUTURES

    1,830.20
    +5.40 (+0.30%)
     
  • DOW

    31,438.26
    -62.42 (-0.20%)
     
  • BTC-GBP

    16,967.59
    -376.98 (-2.17%)
     
  • CMC Crypto 200

    454.11
    -7.68 (-1.66%)
     
  • ^IXIC

    11,524.55
    -83.07 (-0.72%)
     
  • ^FTAS

    4,004.23
    +29.16 (+0.73%)
     

CompuGroup Medical publishes Annual Report for 2021 and proposes dividend at prior year's level

  • Oops!
    Something went wrong.
    Please try again later.
·3-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

DGAP-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Dividend
07.04.2022 / 09:18
The issuer is solely responsible for the content of this announcement.

  • The 2021 Annual Report has been published

  • Proposed dividend at previous year's level of EUR 0.50

  • Annual General Meeting is scheduled for May 19, 2022

Koblenz. CompuGroup Medical SE & Co. KGaA has announced with today's publication of its Annual Report for the fiscal year (FY) 2021 that the Executive Directors and the Supervisory Board intend to propose a dividend of EUR 0.50 per share, the same level as last year, at the Annual General Meeting 2022.
"Despite our upfront investments for higher sustained organic growth in the future we were able to generate record free cash flow in FY 2021," commented Michael Rauch, CFO of CompuGroup Medical. "We will continue to use the cash primarily for financing growth as well as returning it to our shareholders in the form of dividends and share buybacks."
Based on the current 52.3 million shares with a dividend entitlement, the estimated total dividend payout will be set at around EUR 26.1 million. Measured against free cash flow and net earnings in 2021, the payout ratio will thus be at around 26 percent. The preliminary figures for FY 2021 and the forecast for 2022 had already been announced on March 10, 2022.

The annual report for FY 2021 is now available to view on the company's website at www.cgm.com/ir-publications.


About CompuGroup Medical SE & Co. KGaA
CompuGroup Medical is one of the leading e-health companies in the world. With a revenue base of EUR 1.025 billion in 2021, its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories, hospitals and social institutions. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of more than 1.6 million users, including doctors, dentists, pharmacists, and other healthcare professionals in inpatient and outpatient facilities. With locations in 19 countries and products in 56 countries worldwide, CompuGroup Medical is the e-health company with one of the highest coverages among healthcare professionals. More than 8,500 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.

Contact for Media Representatives:
Alexander Weimer
Head of Corporate Communications
P +49 261 8000-6100
M press@cgm.com

Contact for Analysts and Investors:
Claudia Thomé
Corporate Vice President Investor Relations
P +49 160 3630362
M claudia.thome@cgm.com


07.04.2022 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language:

English

Company:

CompuGroup Medical SE & Co. KGaA

Maria Trost 21

56070 Koblenz

Germany

Phone:

+49 (0)160 3630362

Fax:

+49 (0)261 8000 3200

E-mail:

investor@cgm.com

Internet:

www.cgm.com

ISIN:

DE000A288904

WKN:

A28890

Indices:

SDAX, TecDAX

Listed:

Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange

EQS News ID:

1322513


 

End of News

DGAP News Service

show this
show this
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting